Niagen Bioscience taps Evotec for NB4168 preclinical drug studies

Go back to Niagen Bioscience taps Evotec for NB4168 preclinical drug studies
EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) Delayed: 1.96 --0 (-0%)
Previous Close $1.96    52 Week High $16.39 
Open $1.94    52 Week Low $13.22 
Day High $1.96    P/E N/A 
Day Low $1.92    EPS $-1.61 
Volume 30,202       

(NASDAQ: NAGE) Delayed: 3.04 +0.02 (0.66%)
Previous Close $3.02    52 Week High
Open $3.01    52 Week Low
Day High $3.05    P/E N/A 
Day Low $2.96    EPS
Volume 616,794